BCIQ Profiles

Company Profile Report

Seventure leads Axial's $25M series B

Axial Biotherapeutics Inc. (Boston, Mass.) raised a $25 million series B led by Seventure Partners on the back of its Parkinson's disease and autism microbiome programs.

Existing investors Longwood Fund, Domain Associates and Heritage Medical

Read the full 348 word article

How to gain access

Continue reading with a
two-week free trial.